EOLS
Evolus Inc
NASDAQ · Pharmaceuticals
$4.50
+0.09 (+2.04%)
Open$4.50
Previous Close$4.41
Day High$4.60
Day Low$4.46
52W High$57.39
52W Low$25.09
Volume—
Avg Volume579.8K
Market Cap291.69M
P/E Ratio15.57
EPS$2.53
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+1,039.8% upside
Current
$4.50
$4.50
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 70.51M | 74.40M | 59.96M |
| Net Income | 18.85M | 20.76M | 14.77M |
| Profit Margin | 26.7% | 27.9% | 24.6% |
| EBITDA | 37.17M | 38.85M | 31.46M |
| Free Cash Flow | 11.55M | 15.01M | 10.49M |
| Rev Growth | -5.3% | +16.8% | +10.8% |
| Debt/Equity | 0.97 | 0.90 | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |